Trial
NCT03573505
An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary Fibrosis
Phase IITERMINATEDSAFETYConfidence: HIGH
Sponsor
Biogen
Collaborators
—
Condition
Idiopathic Pulmonary Fibrosis
Intervention
BG00011
Why stopped
Study was stopped because of safety concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-12-11